IDEX Reports Strong Q1 2026 Results with Organic Sales Growth and Margin Expansion
IDEX (NYSE:IEX) reported first-quarter 2026 results that exceeded expectations, driven by growth in its 'advantage markets' and the 80/20 operating philosophy. The company achieved 5% organic sales growth and a 26% adjusted EBITDA margin, with a 50 basis point year-over-year margin expansion. Orders were also up 10% organically, indicating strong demand.
Tickers: $IEX
Topics: Earnings EBITDA Financial Performance Order Trends Sales Growth